Terms: = Lung cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Clinical Outcome
7 results:
1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
2. Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification.
Alay A; Cordero D; Hijazo-Pechero S; Aliagas E; Lopez-Doriga A; Marín R; Palmero R; Llatjós R; Escobar I; Ramos R; Padrones S; Moreno V; Nadal E; Solé X
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33632900
[TBL] [Abstract] [Full Text] [Related]
3. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
[TBL] [Abstract] [Full Text] [Related]
4. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic modifications of histone h4 in lung neuroendocrine tumors.
Li F; Ye B; Hong L; Xu H; Fishbein MC
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):389-94. PubMed ID: 21415707
[TBL] [Abstract] [Full Text] [Related]
6. Global levels of histone modifications predict prognosis in different cancers.
Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
[TBL] [Abstract] [Full Text] [Related]
7. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.
Ostwald C; Gogacz P; Hillmann T; Schweder J; Gundlach K; Kundt G; Barten M
Int J Cancer; 2000 Oct; 88(1):82-6. PubMed ID: 10962443
[TBL] [Abstract] [Full Text] [Related]
